4,0
21. März 2017
Mitarbeiter (anonym)
Ehemaliger Mitarbeiter
South San Francisco, CA
Empfehlen
CEO-Befürwortung
Geschäftsprognose
Pros
Best drug developer in the world. Great minds and thorough strategic assessment of opportunities. Play in oncology and other specialty areas which allow for great ROI.
Kontras
Gone but not forgotten. Current version of company is slowly evolving to become more like Roche. Loss of Ian is a big deal. Bill is not a suitable replacement.